Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity

Area of Science:

• Oncology
• Cancer Metabolism
• Melanoma Research

Background:

• Tumor heterogeneity poses a significant challenge to cancer therapy.
• The interplay between cellular metabolism, phenotype, and lineage restriction in cancer remains incompletely understood.
• Microphthalmia-associated transcription factor (MITF) downregulation marks the switch from proliferative to invasive phenotypes in melanoma, but its precise role is unclear.

Purpose of the Study:

• To investigate the role of MITF in regulating melanoma cell metabolism and phenotype.
• To determine if lineage-restricted mechanisms control metabolic vulnerabilities in melanoma.
• To elucidate how MITF influences proliferation, invasion, and metastasis.

Main Methods:

• Analysis of MITF's role as a transcriptional activator.
• Investigating the activity of stearoyl-CoA desaturase (SCD) in melanoma cells.
• Assessing the impact of SCD inhibition on MITF-high and MITF-low melanoma cells.
• Evaluating the effects of the MITF-SCD axis on metastasis and inflammatory signaling.

Main Results:

• MITF activates the lipogenic enzyme SCD, which is essential for MITF-high melanoma cell proliferation.
• MITF-low melanoma cells exhibit insensitivity to SCD inhibition.
• The MITF-SCD axis was found to suppress metastasis, inflammatory signaling, and ATF4-mediated de-differentiation.
• Fatty acid composition driven by the MITF-SCD axis is a key factor in melanoma phenotype switching.

Conclusions:

• MITF acts as a lineage-specific regulator of metabolic reprogramming in melanoma.
• Melanoma cell phenotype is a critical determinant of response to lipid metabolism-targeting drugs.
• Targeting the MITF-SCD metabolic axis presents a potential therapeutic strategy for melanoma.